Find an Immunologist
Login
Donate
Menu
Meetings
2025 Annual Meeting
Claim CME
Diagnostic School
CIS/Grifols AIM Program
CIS Summer School
CIS Meeting Attendee Code of Conduct
Policy on Posting Outside Meeting Advertisments
Related Meetings
News
Latest News
Advocacy for Personalized IgG Therapy Choices
ARPC1B quality of life ESID-EBMT-CIS
CIS Statement on the Passing of Vicki Modell
IDF Funding Announcement
President's Message
Statement on Proposed FDA Laboratory Developed Test Rules
WAS2024 Wiskott Aldrich Syndrome Symposium, Milan, Italy
Endorsement of IPOPI Advocacy Statement on PIDs and Disability Support
Journal of Clinical Immunology (JoCI) Update
Statement on SCIG and IVIG
Resources
Find an Immunologist
Webinars
Listserv
DLI Lab Directory
Job Board
WEBbook of Biologic Therapies
Speakers Bureau
Video Library
Funding/Grants
I-CIS Innovation Grants
Advocacy
Related Organizations
COVID-19 Resources
Membership
Membership Categories
Member Benefits
Become a Member
Renew My Membership
Early Career Immunologists
Membership Code of Conduct
About
Get Involved
Leadership
Bylaws
Committees & Task Forces
Fellows-In-Training
Fellows of the CIS
Strategic Plan
Foundation
CIS Foundation Scholar Grants
IAPIDS
Awards
ACCME Accreditation
Contact Us
Find an Immunologist
Login
Donate
Latest News
Email
Print
Latest News
News
Latest News
Advocacy for Personalized IgG Therapy Choices
ARPC1B quality of life ESID-EBMT-CIS
CIS Statement on the Passing of Vicki Modell
IDF Funding Announcement
President's Message
Statement on Proposed FDA Laboratory Developed Test Rules
WAS2024 Wiskott Aldrich Syndrome Symposium, Milan, Italy
Endorsement of IPOPI Advocacy Statement on PIDs and Disability Support
Journal of Clinical Immunology (JoCI) Update
Statement on SCIG and IVIG
Please wait while we gather your results.
WAS2024 Wiskott Aldrich Syndrome Symposium, Milan, Italy
Learn More
CIS Statement on the Passing of Vicki Modell
Learn More
IDF Funding Announcement
Learn More
Statement on Proposed FDA Laboratory Developed Test Rules
Learn More
President's Message
Learn More
top